OpenRx Open Medications Explorer
© 2026 OpenRx · public-domain U.S. government data
On this page

Tanzeum

albiglutide

351(a) Standalone BLA

Overview

Source: Purple Book
Proprietary name
Tanzeum
Proper name
albiglutide
Licence type
351(a)
BLA number
125431
Applicant
GlaxoSmithKline LLC
Center
CDER
Presentations
2
First licensure
—

Presentations

Source: Purple Book
Every strength and presentation recorded in the Purple Book for this product.
Strength Dosage form Route Presentation Status Licensed
30MG For Injection Subcutaneous Autoinjector Disc April 15, 2014
50MG For Injection Subcutaneous Autoinjector Disc April 15, 2014

Sources for this page

Purple Book FDA Licence type, presentations, reference product, exclusivity